ReP USP - Resultado da busca

Artigo de periodico
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes (2017)
Lopes, Matheus Rodrigues; Pereira, João Kleber Novais; Campos, Paula de Melo; Machado Neto, João Agostinho ; Traina, Fabiola; Saad, Sara Teresinha Olalla; Favaro, Patricia
Source: Scientific Reports. Unidades: ICB, FMRP
Subjects: MEDULA ÓSSEA, PROLIFERAÇÃO CELULAR, QUIMIOTAXIA, CITOCINAS, LEUCEMIA MIELOIDE AGUDA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. Scientific Reports, v. 7, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1038/srep40707. Acesso em: 07 nov. 2024.
APA
Lopes, M. R., Pereira, J. K. N., Campos, P. de M., Machado Neto, J. A., Traina, F., Saad, S. T. O., & Favaro, P. (2017). De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. Scientific Reports, 7( 1). doi:10.1038/srep40707
NLM
Lopes MR, Pereira JKN, Campos P de M, Machado Neto JA, Traina F, Saad STO, Favaro P. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/srep40707
Vancouver
Lopes MR, Pereira JKN, Campos P de M, Machado Neto JA, Traina F, Saad STO, Favaro P. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2024 nov. 07 ] Available from: https://doi.org/10.1038/srep40707
Artigo de periodico
IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients (2017)
Lopes, Matheus Rodrigues; Pereira, João Kleber Novais; Traina, Fabiola; Campos, Paula de Melo; Machado Neto, João Agostinho ; Saad, Sara Teresinha Olalla; Favaro, Patricia
Source: Applied Cancer Research. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE, IMUNOLOGIA, INTERLEUCINAS, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients. Applied Cancer Research, v. 37, p. 6 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s41241-017-0017-9. Acesso em: 07 nov. 2024.
APA
Lopes, M. R., Pereira, J. K. N., Traina, F., Campos, P. de M., Machado Neto, J. A., Saad, S. T. O., & Favaro, P. (2017). IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients. Applied Cancer Research, 37, 6 . doi:10.1186/s41241-017-0017-9
NLM
Lopes MR, Pereira JKN, Traina F, Campos P de M, Machado Neto JA, Saad STO, Favaro P. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients [Internet]. Applied Cancer Research. 2017 ; 37 6 .[citado 2024 nov. 07 ] Available from: https://doi.org/10.1186/s41241-017-0017-9
Vancouver
Lopes MR, Pereira JKN, Traina F, Campos P de M, Machado Neto JA, Saad STO, Favaro P. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients [Internet]. Applied Cancer Research. 2017 ; 37 6 .[citado 2024 nov. 07 ] Available from: https://doi.org/10.1186/s41241-017-0017-9
Artigo de periodico-carta/editorial
Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta] (2015)
Xavier-Ferrucio, Juliana M.; Pericole, Fernando Vieira; Lopes, Matheus Rodrigues; Latuf-Filho, Paulo; Barcellos, Karin Spät Albino; Dias, Amanda Inácio; Campos, Paula de Melo; Traina, Fabiola; Vassallo, José; Saad, Sara Teresinha Olalla; Favaro, Patricia
Source: Haematologica. Unidade: FMRP
Subjects: HEMATOPOESE, LEUCEMIA MIELOIDE AGUDA, FATORES DE RISCO, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XAVIER-FERRUCIO, Juliana M. et al. Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.3324/haematol.2015.124040. Acesso em: 07 nov. 2024. , 2015
APA
Xavier-Ferrucio, J. M., Pericole, F. V., Lopes, M. R., Latuf-Filho, P., Barcellos, K. S. A., Dias, A. I., et al. (2015). Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]. Haematologica. Pavia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.3324/haematol.2015.124040
NLM
Xavier-Ferrucio JM, Pericole FV, Lopes MR, Latuf-Filho P, Barcellos KSA, Dias AI, Campos P de M, Traina F, Vassallo J, Saad STO, Favaro P. Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta] [Internet]. Haematologica. 2015 ; 100( 12):[citado 2024 nov. 07 ] Available from: https://doi.org/10.3324/haematol.2015.124040
Vancouver
Xavier-Ferrucio JM, Pericole FV, Lopes MR, Latuf-Filho P, Barcellos KSA, Dias AI, Campos P de M, Traina F, Vassallo J, Saad STO, Favaro P. Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta] [Internet]. Haematologica. 2015 ; 100( 12):[citado 2024 nov. 07 ] Available from: https://doi.org/10.3324/haematol.2015.124040
Artigo de periodico
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia (2015)
Pereira, João Kleber Novais; Machado Neto, João Agostinho ; Lopes, Matheus Rodrigues; Morini, Beatriz Corey; Traina, Fabíola; Costa, Fernando Ferreira; Saad, Sara Teresinha Olalla; Favaro, Patricia
Source: European Journal of Cancer. Unidade: FMRP
Subjects: LEUCEMIA, LINFOMA, LINHAGEM CELULAR, FÁRMACOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, João Kleber Novais et al. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia. European Journal of Cancer, v. 51, n. 14, p. 2076–2085, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2015.07.018. Acesso em: 07 nov. 2024.
APA
Pereira, J. K. N., Machado Neto, J. A., Lopes, M. R., Morini, B. C., Traina, F., Costa, F. F., et al. (2015). Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia. European Journal of Cancer, 51( 14), 2076–2085. doi:10.1016/j.ejca.2015.07.018
NLM
Pereira JKN, Machado Neto JA, Lopes MR, Morini BC, Traina F, Costa FF, Saad STO, Favaro P. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia [Internet]. European Journal of Cancer. 2015 ; 51( 14): 2076–2085.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ejca.2015.07.018
Vancouver
Pereira JKN, Machado Neto JA, Lopes MR, Morini BC, Traina F, Costa FF, Saad STO, Favaro P. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia [Internet]. European Journal of Cancer. 2015 ; 51( 14): 2076–2085.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ejca.2015.07.018
Artigo de periodico
Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion (2014)
Roversi, Fernanda Marconi; Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Longhini, Ana Leda F.; Duarte, Adriana Silva Santos; Baratti, Mariana O.; Palodetto, Bruna; Corrocher, Flávia Adolfo; Pericole, Fernando V.; Campos, Paula de Melo; Favaro, Patricia; Traina, Fabíola; Saad, Sara Teresinha Olalla
Source: Stem Cells and Development. Unidade: FMRP
Subjects: DOENÇAS HEMATOLÓGICAS, HEMATOPOESE, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVERSI, Fernanda Marconi et al. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion. Stem Cells and Development, v. 23, n. 10, p. 1109-1120, 2014Tradução . . Disponível em: https://doi.org/10.1089/scd.2013.0441. Acesso em: 07 nov. 2024.
APA
Roversi, F. M., Lopes, M. R., Machado Neto, J. A., Longhini, A. L. F., Duarte, A. S. S., Baratti, M. O., et al. (2014). Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion. Stem Cells and Development, 23( 10), 1109-1120. doi:10.1089/scd.2013.0441
NLM
Roversi FM, Lopes MR, Machado Neto JA, Longhini ALF, Duarte ASS, Baratti MO, Palodetto B, Corrocher FA, Pericole FV, Campos P de M, Favaro P, Traina F, Saad STO. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion [Internet]. Stem Cells and Development. 2014 ; 23( 10): 1109-1120.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1089/scd.2013.0441
Vancouver
Roversi FM, Lopes MR, Machado Neto JA, Longhini ALF, Duarte ASS, Baratti MO, Palodetto B, Corrocher FA, Pericole FV, Campos P de M, Favaro P, Traina F, Saad STO. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion [Internet]. Stem Cells and Development. 2014 ; 23( 10): 1109-1120.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1089/scd.2013.0441
Trabalho de evento-resumo
FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation (2013)
Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Traina, Fabíola; Pereira, João Kleber Novais; Lorand-Metze, Irene; Costa, Fernando Ferreira; Saad, Sara Teresinha Ollala; Favaro, Patricia
Source: Abstracts, Program and Personal Scheduler. Conference titles: Annual Meeting and Exposition of American Society of Hematology (ASH). Unidade: FMRP
Subjects: DOENÇAS HEMATOLÓGICAS, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper60188.html. Acesso em: 07 nov. 2024.
APA
Lopes, M. R., Machado Neto, J. A., Traina, F., Pereira, J. K. N., Lorand-Metze, I., Costa, F. F., et al. (2013). FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper60188.html
NLM
Lopes MR, Machado Neto JA, Traina F, Pereira JKN, Lorand-Metze I, Costa FF, Saad STO, Favaro P. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 07 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper60188.html
Vancouver
Lopes MR, Machado Neto JA, Traina F, Pereira JKN, Lorand-Metze I, Costa FF, Saad STO, Favaro P. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 07 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper60188.html
Trabalho de evento-resumo
Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression (2013)
Roversi, Fernanda Marconi; Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Longhini, Ana Leda; Duarte, Adriana Silva Santos; Palodetto, Bruna; Corrocher, Flavia Adolfo; Campos, Paula de Melo; Baratti, Mariana O.; Pericole, Fernando V.; Favaro, Patricia; Traina, Fabíola; Saad, Sara Teresinha Ollala
Source: Abstracts, Program and Personal Scheduler. Conference titles: Annual Meeting and Exposition of American Society of Hematology (ASH). Unidade: FMRP
Subjects: HEMATOPOESE, DOENÇAS HEMATOLÓGICAS, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVERSI, Fernanda Marconi et al. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper57527.html. Acesso em: 07 nov. 2024.
APA
Roversi, F. M., Lopes, M. R., Machado Neto, J. A., Longhini, A. L., Duarte, A. S. S., Palodetto, B., et al. (2013). Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper57527.html
NLM
Roversi FM, Lopes MR, Machado Neto JA, Longhini AL, Duarte ASS, Palodetto B, Corrocher FA, Campos P de M, Baratti MO, Pericole FV, Favaro P, Traina F, Saad STO. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 07 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper57527.html
Vancouver
Roversi FM, Lopes MR, Machado Neto JA, Longhini AL, Duarte ASS, Palodetto B, Corrocher FA, Campos P de M, Baratti MO, Pericole FV, Favaro P, Traina F, Saad STO. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2024 nov. 07 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper57527.html
Artigo de periodico
FMNL1 promotes proliferation and migration of leukemia cells (2013)
Favaro, Patricia; Traina, Fabiola; Machado Neto, João Agostinho ; Lazarini, Mariana; Lopes, Matheus Rodrigues; Pereira, João Kleber Novais; Costa, Fernando Ferreira; Infante, Elvira; Ridley, Anne J.; Saad, Sara Teresinha Ollala
Source: Journal of Leukocyte Biology. Unidade: FMRP
Subjects: LEUCEMIA, APOPTOSE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAVARO, Patricia et al. FMNL1 promotes proliferation and migration of leukemia cells. Journal of Leukocyte Biology, v. 94, n. 3, p. 503-512, 2013Tradução . . Disponível em: https://doi.org/10.1189/jlb.0113057. Acesso em: 07 nov. 2024.
APA
Favaro, P., Traina, F., Machado Neto, J. A., Lazarini, M., Lopes, M. R., Pereira, J. K. N., et al. (2013). FMNL1 promotes proliferation and migration of leukemia cells. Journal of Leukocyte Biology, 94( 3), 503-512. doi:10.1189/jlb.0113057
NLM
Favaro P, Traina F, Machado Neto JA, Lazarini M, Lopes MR, Pereira JKN, Costa FF, Infante E, Ridley AJ, Saad STO. FMNL1 promotes proliferation and migration of leukemia cells [Internet]. Journal of Leukocyte Biology. 2013 ; 94( 3): 503-512.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1189/jlb.0113057
Vancouver
Favaro P, Traina F, Machado Neto JA, Lazarini M, Lopes MR, Pereira JKN, Costa FF, Infante E, Ridley AJ, Saad STO. FMNL1 promotes proliferation and migration of leukemia cells [Internet]. Journal of Leukocyte Biology. 2013 ; 94( 3): 503-512.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1189/jlb.0113057
Artigo de periodico
IL10 inversely correlates with the percentage of CD8+ cells in MDS patients (2013)
Lopes, Matheus Rodrigues; Traina, Fabiola; Campos, Paula de Melo; Pereira, João Kleber Novais; Machado Neto, João Agostinho ; Machado, Helymar da Costa; Gilli, Simone Cristina Olenscki; Saad, Sara Teresinha Olalla; Favaro, Patricia
Source: Leukemia Research. Unidade: FMRP
Subjects: IDOSOS, DOENÇAS HEMATOLÓGICAS, REGULAÇÃO GÊNICA, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research, v. 37, n. 5, p. 541-546, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.01.019. Acesso em: 07 nov. 2024.
APA
Lopes, M. R., Traina, F., Campos, P. de M., Pereira, J. K. N., Machado Neto, J. A., Machado, H. da C., et al. (2013). IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research, 37( 5), 541-546. doi:10.1016/j.leukres.2013.01.019
NLM
Lopes MR, Traina F, Campos P de M, Pereira JKN, Machado Neto JA, Machado H da C, Gilli SCO, Saad STO, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients [Internet]. Leukemia Research. 2013 ; 37( 5): 541-546.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.leukres.2013.01.019
Vancouver
Lopes MR, Traina F, Campos P de M, Pereira JKN, Machado Neto JA, Machado H da C, Gilli SCO, Saad STO, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients [Internet]. Leukemia Research. 2013 ; 37( 5): 541-546.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.leukres.2013.01.019

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Indexado em